Provider
QP56-25 MHCP Enhanced Authorization Submissions through Availity Essentials
Program effective Date: Jul 09, 2025
Program effective Date: Jul 09, 2025
Program effective Date: Jul 09, 2025
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.